Catalent Pharma Solutions has entered a global alliance with PAREXEL to help streamline the clinical trial supply process. The alliance aims to provide a seamless, fully integrated service offering to ensure the timely and efficient delivery of clinical trial materials.
The alliance will provide the following services and technologies: planning and development of supply strategies, material supply and demand forecasting, central and local clinical trial and ancillary material sourcing, clinical manufacturing and packaging solutions, worldwide regulatory and import/export management, global and local storage as well as distribution to trial sites, depot, site and patient inventory management, material return and destruction/disposition.
“As clinical trials become more complex, we feel it is imperative to help sponsors devise supply strategies and organize consistent manufacturing, packaging, and delivery of trial-related supplies to locations around the world,” said Gerry Hepburn, chief operating officer, vice president and general manager of Clinical Supply Services at Catalent. “PAREXEL, with its extensive and unparalleled track record in clinical development, is the ideal partner for Catalent in this alliance, which will enable our customers to compete more effectively in the global marketplace.”
“One of the most important steps in creating a strong, efficient clinical trial material supply chain is selecting a partner with innovative clinical packaging solutions and established global operations to oversee and coordinate all aspects of each critical supply chain stage,” said Kurt Norris, corporate vice president, Clinical Logistics Services, PAREXEL. “In establishing this alliance with Catalent, we have chosen a partner that is uniquely positioned to help biopharmaceutical companies reach critical development milestones through more efficient delivery of clinical trial supplies.”